TY - JOUR T1 - The Use of Transvaginal Ultrasound in Type II Endometrial Cancer JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 858 LP - 862 DO - 10.1097/IGC.0000000000000423 VL - 25 IS - 5 AU - Caroline C. Billingsley AU - Kimberly A. Kenne AU - Catherine D. Cansino AU - Floor J. Backes AU - David E. Cohn AU - David M. O’Malley AU - Larry J. Copeland AU - Jeffrey M. Fowler AU - Ritu Salani Y1 - 2015/06/01 UR - http://ijgc.bmj.com/content/25/5/858.abstract N2 - Objective To determine the use of the transvaginal ultrasound (TVUS) in postmenopausal women with type II endometrial cancer.Methods/Materials A retrospective review was conducted for 173 women with pathology proven type II endometrial cancer at a single institution. Those who underwent preoperative TVUS were included, and the following data were obtained: endometrial stripe (EMS) measurement, uterine and/or adnexal findings, and uterine size/volume. Clinicopathologic factors were abstracted. Descriptive and regression analyses were performed.Results Fifty-eight women comprised the cohort, and the median age was 66.5 years (50–85 years). The most commonly reported symptom was postmenopausal bleeding in 53 patients (91.4%). The EMS was reported as thin (⩽5mm) or indistinct in 16 patients (27.5%). Approximately 60% of patients had 1 or more ultrasound abnormalities: intracavitary mass (31%), intracavitary fluid (12.1%), myometrial lesion (31.03%), and adnexal mass (12.1%). Poorly differentiated endometrioid cancer (53.45%) represented the predominant histology. Of the 16 (27.5%) women with a thin/indistinct EMS, 5 women (8.6%) did not have any abnormal ultrasound findings whatsoever.Conclusions Women with type II endometrial cancer had a thin/indistinct EMS on TVUS in approximately 25% of cases. Lack of any ultrasound abnormality, including a thickened EMS, was noted in approximately 10% of patients. The use of TVUS, which has been of value in type I cancer, is limited in type II endometrial cancer. Therefore, endometrial sampling should be included in the evaluation of all women with postmenopausal bleeding, regardless of EMS thickness. ER -